These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7243391)

  • 1. Hyperlipidemia in children with chronic renal insufficiency.
    Papadopoulou ZL; Sandler P; Tina LU; Jose PA; Calcagno PL
    Pediatr Res; 1981 Jun; 15(6):887-91. PubMed ID: 7243391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further definition of lipid-lipoprotein abnormalities in children with various degrees of chronic renal insufficiency.
    Zacchello G; Pagnan A; Sidran MP; Ziron L; Braggion M; Pavanello L; Facchin P
    Pediatr Res; 1987 May; 21(5):462-5. PubMed ID: 3588083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E
    Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
    Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
    Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typing of hyperlipoproteinemia in an Israel hospital.
    Eisenberg S
    Isr J Med Sci; 1976 Nov; 12(11):1261-8. PubMed ID: 1017927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipid concentrations correlate with the progression of chronic renal failure.
    Yang WQ; Song NG; Ying SS; Liang HQ; Zhang YJ; Wei MJ; Wu KF
    Clin Lab Sci; 1999; 12(2):104-8. PubMed ID: 10387487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of decreasing renal function on lipoprotein profiles.
    Attman PO; Samuelsson O; Alaupovic P
    Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Alaupovic P
    Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic hyperlipoproteinemia: correlation with residual renal function and duration of maintenance hemodialysis.
    Frank W; Rao TK; Manis T; Delano BG; Avram MM; Saxena AK; Carter AC; Friedman EA
    Trans Am Soc Artif Intern Organs; 1977; 23():59-64. PubMed ID: 910386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy.
    Goren A; Stankiewicz H; Goldstein R; Drukker A
    Pediatrics; 1991 Aug; 88(2):265-8. PubMed ID: 1861924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein Lp(a) in patients with chronic renal insufficiency on hemodialysis].
    Cuxart M; Sans R; Vicente M; Pérez Gallofré A; Masdeu Jufré S; Ponsatí C
    Med Clin (Barc); 1989 May; 92(20):769-71. PubMed ID: 2529402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta 2 microglobulin. Index of glomerular filtration in children].
    Leroy D; Mauriat F; Dechaux M; Chopin N; Broyer M; Sachs C
    Arch Fr Pediatr; 1984 Jan; 41(1):43-7. PubMed ID: 6372730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.